Hostname: page-component-857557d7f7-gtc7z Total loading time: 0.001 Render date: 2025-11-25T02:58:42.367Z Has data issue: false hasContentIssue false
  • English
  • Français

Methicillin-Resistant Staphylococcus aureus Epidemiology and Control in Belgian Hospitals, 1991 to 1995

Published online by Cambridge University Press:  02 January 2015

Marc J. Struelens ,
Olivier Ronveaux ,
Béatrice Jans ,
Raf Mertens  and
Groupement pour le Dépistage, l'Etude et la Prévention des Infections Hospitalières
Marc J. Struelens*
Affiliation:
Hospital Epidemiology and Infection Control Unit, Department of Microbiology, Institute of Hygiene and Epidemiology, Brussels, Belgium
Olivier Ronveaux
Affiliation:
Hôpital Erasme and Infectious Diseases Epidemiology Unit, School of Public Health, Université Libre de Bruxelles, Brussels, Belgium, and from the Epidemiology Unit, Institute of Hygiene and Epidemiology, Brussels, Belgium
Béatrice Jans
Affiliation:
Hôpital Erasme and Infectious Diseases Epidemiology Unit, School of Public Health, Université Libre de Bruxelles, Brussels, Belgium, and from the Epidemiology Unit, Institute of Hygiene and Epidemiology, Brussels, Belgium
Raf Mertens
Affiliation:
Hôpital Erasme and Infectious Diseases Epidemiology Unit, School of Public Health, Université Libre de Bruxelles, Brussels, Belgium, and from the Epidemiology Unit, Institute of Hygiene and Epidemiology, Brussels, Belgium
*
Microbiology Department, Hôpital Erasme, 808 route de Lennik, 1070 Brussels, Belgium
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: To describe the Belgian methicillin-resis-tant Staphylococcus aureus (MRSA) surveillance network, the evolution of methods used in Belgian hospitals for MRSA detection and control, and MRSA incidence from 1994 to1995.

Design, Setting, and Participants: Questionnaire surveys; infection control physicians from acute-care hospitals in Belgium.

Intervention: Publication of national guidelines for MRSA control in 1993.

Results: The participation rate in surveys ranged from 42% to 57% of hospitals. In 1995, 88% of participants detected MRSA strains by disk diffusion tests, with little improvement in standardization since 1991. More centers employed the oxacillin agar screen method (27%), automated systems (29%), or a combination of methods (29%) than in 1991 (P<.005). Between 1991 and 1995, the proportion of hospitals reporting MRSA control measures increased from 68% to 95% (P<.01). Practices that were used increasingly included patient placement in private room (from 50% to 93%, P<.01) and hand decontamination with antiseptic (from 43% to 87%, P<.01). The proportion of centers that reported screening MRSA carriers and treating them topically increased two- and threefold, respectively (P<.05). Surveillance data from 1994 to 1995 showed that MRSA represented a mean of 21.3% of S aureus clinical isolates (range, 1.6% to 62.4%). The median incidence of nosocomial MRSA acquisition was 2.8 per 1,000 admissions, with a wide range (0 to 13.7 per 1,000 admissions) across hospitals of all sizes. The median incidence decreased over the first three semesters of surveillance in hospitals with continuous participation.

Conclusion: MRSA detection and control measures have improved in Belgian hospitals after publication of national guidelines. However, MRSA incidence rates show the persistence of nosocomial transmission, with large variations between centers. The national MRSA surveillance network should indicate whether control efforts eventually will curb the problem.

Information

Type
From the Fourth International Conference on the Prevention of Infection
Information
Infection Control & Hospital Epidemiology , Volume 17 , Issue 8 , August 1996 , pp. 503 - 508
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1996 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1. Voss, A, Milatovic, D, Wallrauch-Schwarz, C, Rosdahl, VT, Braveny, I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994;13:50–55.Google Scholar
2. Panlilio, AL, Culver, DG, Gaynes, RP. Methicillin-resistant Staphylococcus aureus in US hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992;13:582–586.Google Scholar
3. Vandenbroucke-Grauls, CM. Control of methicillin-resistant Staphylococcus aureus in The Netherlands. In: Coello, R, Casewell, MW, eds. Methicillin resistant Staphylococcus aureus. Kent, England: Wells Medical Ltd; 1993.Google Scholar
4. Boyce, JM. Patterns of methicillin-resistant Staphylococcus aureus prevalence. Infect Control Hosp Epidemiol 1991;12:79–82.Google Scholar
5. Rosdahl, VT, Knudsen, AM. The decline of methicillin resistance among Danish Staphylococcus aureus strains. Infect Control Hosp Epidemiol 1991;12:83–88.Google Scholar
6. Institut d'Hygiène et d'Epidémiologie, Ministère de la Santé Publique et de l'Environnement. Etude des souches de Staphylococcus aureus isolés d'hémoculture en milieu hospitalier. 1985;1–21.Google Scholar
7. Van der Auwera, P, Godard, C, Denis, C, De Maeyer, S, Vanhoof, R. In vitro activities of new antimicrobial agents against multiresistant Staphylococcus aureus isolated from septicemic patients during a Belgian national survey from 1983 to 1985. Antimicrob Agents Chemother 1990;34:2260–2262.Google Scholar
8. Struelens, MJ, Mertens, R, the Groupement pour le Dépistage, l'Etude et la Prévention des Infections Hospitalières. National survey of methicillin-resistant Staphylococcus aureus in Belgian hospitals: detection methods, prevalence trends and infection control measures. Eur J Clin Microbiol Infect Dis 1994;13:54–63.Google Scholar
9. The Groupement pour le Dépistage, l'Etude et la Prévention des Infections Hospitalières—Groep ter Opsporing, Studie en Preventie van de Infecties in de Ziekenhuizen (GDEPIH-GOSPIZ). Guidelines for control and prevention of methicillin-resistant Staphylococcus aureus transmission in Belgian hospitals. Acta Clin Belg 1994;49:108–113.Google Scholar
10. Struelens, MJ. Can we control the rise of methicillin-resistant Staphylococcus aureus? Acta Clin Belg 1994;49:63–67.Google Scholar
11. Jorgensen, JM. Mechanisms of methicillin resistance in Staphylococcus aureus and methods for laboratory detection. Infect Control Hosp Epidemiol 1991;12:14–19.Google Scholar
12. Boyce, JM. Methicillin-resistant Staphylococcus aureus in hospitals and long term care facilities: microbiology, epidemiology and preventive measures. Infect Control Hosp Epidemiol 1992;13:725–737.Google Scholar
13. Mackenzie, AMR, Richardson, H, Lannigan, R, Wood, D. Evidence that the National Committee for Clinical Laboratory Standards disk test is less sensitive than the screen plate for detection of low-expression-class methicillin-resistant Staphylococcus aureus . J Clin Microbiol 1995;33:1909–1911.Google Scholar
14. Struelens, MJ, Nonhoff, C, Van der Auwera, P, Mertens, R, Serruys, E. Evaluation of Rapid ATB Staph for 5h antimicrobial susceptibility testing of Staphylococcus aureus . J Clin Microbiol 1995;33:2395–2399.Google Scholar
15. Association des pays de la Loire pour l'éviction des infections nosocomiales. Etude épidémiologique multicentrique sur les infections à Staphylococcus aureus résistants à la méticilline dans les hôpitaux de la région des pays de la Loire. Bull Epidemiol Hebdom 1995;27:121–122.Google Scholar
16. Mertens, R, Jans, B, Kurz, X. A computerized nationwide network for nosocomial infection surveillance in Belgium. Infect Control Hosp Epidemiol 1994;15:171–179.Google Scholar
17. Boyce, JM. Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 1991;12:46–54.Google Scholar
18. Casewell, MW, Hill, RLR. Minimal dose requirements for nasal mupirocin and its role in the control of epidemic MRSA. J Hosp Infect 1991;19:35–40.Google Scholar
19. Cookson, BD. Mupirocin resistance in staphylococci. J Antimicrob Agents Chemother 1990;25:497–501.Google Scholar
20. Layton, MC, Patterson, JE. Mupirocin resistance among consecutive isolates of oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus at a University Hospital. J Clin Microbiol 1994;38:1664–1667.Google Scholar